Yarger Wealth Strategies’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$999K Buy
840
+64
+8% +$65.4K 0.36% 55
2026
Q1
$714K Sell
776
-16
-2% -$16.2K 0.29% 62
2025
Q4
$852K Buy
792
+14
+2% +$13.4K 0.37% 47
2025
Q3
$593K Buy
778
+201
+35% +$150K 0.27% 60
2025
Q2
$450K Buy
577
+112
+24% +$87K 0.24% 62
2025
Q1
$384K Buy
465
+15
+3% +$12.5K 0.22% 61
2024
Q4
$347K Buy
450
+104
+30% +$86.1K 0.2% 65
2024
Q3
$306K Buy
346
+14
+4% +$12.6K 0.17% 69
2024
Q2
$301K Buy
332
+56
+20% +$44.8K 0.18% 66
2024
Q1
$215K Buy
+276
New +$196K 0.15% 74

Other funds holding LLY

Yarger Wealth Strategies's LLY Position: Q2 2026 in Review

Yarger Wealth Strategies increased its Eli Lilly (LLY) stake by 8.2% in Q2 2026, buying an estimated $65.4K and bringing the position to 840 shares worth $999K. The position accounts for 0.36% of the portfolio, ranked #55.

Yarger Wealth Strategies first reported a position in LLY in Q1 2024 and has held it in 10 quarters since. 4,618 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Yarger Wealth Strategies held 840 shares of Eli Lilly worth $999K as of Q2 2026.
  • Yarger Wealth Strategies bought 64 Eli Lilly shares in Q2 2026, an estimated $65.4K.
  • Eli Lilly made up 0.36% of Yarger Wealth Strategies's portfolio in Q2 2026, its #55 holding.
  • Yarger Wealth Strategies first reported a position in Eli Lilly in Q1 2024 and has held it in 10 quarters since.
  • 4,618 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Yarger Wealth Strategies's 13F filing for Q2 2026, filed 14 Jul 2026.